Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Journal article
Liu X. et al, (2023), J Infect
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial.
Journal article
Calvert A. et al, (2023), Lancet Microbe
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Journal article
Goldblatt D. et al, (2023), Vaccine
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal article
Shaw RH. et al, (2023), J Infect
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
Journal article
Mao Z. et al, (2023), Vaccine
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials
Journal article
EWER K., (2023), Clinical and Experimental Immunology
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine.
Journal article
Rajan M. et al, (2023), Pediatr Infect Dis J, 42, 66 - 73
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
Journal article
Wildenbeest JG. et al, (2022), Lancet Respir Med
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study.
Journal article
Houben J. et al, (2022), Pediatr Diabetes
Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: A retrospective observational comparison
Journal article
Channon-Wells SW. et al, (2022), BMJ Paediatrics Open, 6
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England.
Journal article
Sapuan S. et al, (2022), Vaccine
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector RSV Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV Seropositive Children 12-24 Months.
Journal article
Stuart A. et al, (2022), J Infect Dis
Elevations in blood glucose before and after the appearance of islet autoantibodies in children.
Journal article
Warncke K. et al, (2022), J Clin Invest, 132
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Journal article
Mentzer AJ. et al, (2022), Nat Med
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials.
Journal article
Bendor-Samuel OM. et al, (2022), Arch Dis Child
Nasopharyngeal carriage of pneumococcus in children in England up to ten years after PCV13 introduction: persistence of serotypes 3 and 19A and emergence of 7C.
Journal article
Tiley KS. et al, (2022), J Infect Dis
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
Journal article
McGinley JP. et al, (2022), J Infect Dis
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021.
Journal article
Ratcliffe H. et al, (2022), Arch Dis Child
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
Journal article
Carr JP. et al, (2022), Clin Microbiol Infect